Product Images Atorvastatin Calcium

Atorvastatin Calcium is a tablet containing 40 mg of medicine. There are a total of 90 tablets in the package. The manufacturer is Apotex Corp, based in Weston, FL 33326. It is repackaged by RemedyRepack Inc. The medication is not available for sale without a prescription. The NDC number for this medication is 70518-1322-01, and the manufacturer's NDC number is 60505-2580-08. It is essential to keep this medication out of reach of children. The directions for use are available in the package insert. Store the medication in a cool and dry place between 20-25°C (88-77°F); excursions permitted at 15-30°C (59-86°F) according to the United States Pharmacopeia (USP).*

Atorvastatin Calcium is a tablet with a strength of 40 mg, and a quantity of 30. It is packaged by Orepack and labeled as RX ONLY. The NDC number is 70518-1322-02, and the source NDC is 60505-2580-08. It was manufactured by Apotex Corp in Weston, FL 33326, and repackaged by RemedyRepack Ine in Indiana, PA 15701. The medication should be kept out of the reach of children and stored at 20-25°C (88-77°F); excursions permitted o 15-30°C (59-86°F) [See USP]. Directions for use are to be found in the package insert, and the LOT # and Expiration date are not available.*

Atorvastatin Calcium is a tablet with a strength of 40 mg. It is packag ed in a quantity of 28 and is intended for prescription use only. The medication should be stored within a temperature range of 20-25°C (68-77°F) and kept away from the reach of children. Information regarding usage of the drug is provided in the package insert, which should be reviewed before administration. The product has been repackaged by RemedyRepack Inc., located in Indiana, USA. The manufacturer is Apotex Corp., Weston, FL 33326. The lot number is not available, and the expiration date is left blank. The Source NDC code for the product is 60505-2580-08, and the packaged NDC is 70518-1322-04.*

The text appears to be a table that shows the percentage of subjects experiencing "E vert" for two different medications, Horvastatin 10 mg and Sorvastatin 80 mg. It also includes a hazard ratio and p-value for these medications in relation to time to first major cardiovascular endpoint. Without further context, it is difficult to provide a more specific description of the text.*